These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33532324)

  • 1. Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
    Tian J; Sun J; Fu G; Xu Z; Chen X; Shi Y; Jin B
    Transl Androl Urol; 2021 Jan; 10(1):356-373. PubMed ID: 33532324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
    Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X
    Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study.
    Huang C; Yu QP; Ding Z; Zhou Z; Shi X
    Cancer Med; 2023 Mar; 12(5):6244-6259. PubMed ID: 36271609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
    Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
    Front Oncol; 2022; 12():895413. PubMed ID: 35928878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy.
    Hu B; Chen R; Chen G; Zheng P; Fu B
    Front Surg; 2023; 10():1121184. PubMed ID: 36911611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
    Schuettfort VM; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; König F; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
    BJU Int; 2022 Feb; 129(2):182-193. PubMed ID: 33650265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.
    Gu Y; Deng H; Wang D; Li Y
    Front Surg; 2021; 8():759162. PubMed ID: 34950695
    [No Abstract]   [Full Text] [Related]  

  • 10. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery.
    Wang J; Shi H; Fan Z; Yang J; Zheng Y; Zeng D; Zhang J; Hai B
    Cancer Med; 2023 Jul; 12(13):14207-14224. PubMed ID: 37199384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis prediction model for a special entity of gastric cancer, linitis plastica.
    Chen X; Zhi Y; Lin Z; Ma J; Mou W; Yu J
    J Gastrointest Oncol; 2021 Apr; 12(2):307-327. PubMed ID: 34012628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study.
    Zhou Z; Mo S; Dai W; Xiang W; Han L; Li Q; Wang R; Liu L; Zhang L; Cai S; Cai G
    Cancer Cell Int; 2019; 19():355. PubMed ID: 31889907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy.
    Bi H; Yan Y; Wang D; Qin Z; Wang G; Ma L; Huang Y; Lu J
    J Cancer; 2021; 12(2):305-315. PubMed ID: 33391427
    [No Abstract]   [Full Text] [Related]  

  • 16. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
    Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder.
    Patel KN; Salunke A; Sharma M; Puj K; Rathod P; Warikoo V; Bakshi G; Pandya SJ
    Clin Genitourin Cancer; 2023 Jun; 21(3):e153-e165. PubMed ID: 36549982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
    Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
    BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
    Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A
    Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.